News | January 10, 2022

BrightInsight Announces Partnership with Sanofi to Bring to Market a Next Generation Digital Companion ApplicationBrightInsight’s Platform has been selected to Accelerate Continuous Development of one of Sanofi’s Best-In-Class Software as a Medical Device SAN JOSE,...

News | January 5, 2022

Edgewise Therapeutics Announces Positive Topline Results From the EDG-5506 Phase 1b Clinical Trial in Adults With Becker Muscular Dystrophy (BMD) – EDG-5506 was well tolerated with no serious adverse events observed – – Pharmacokinetic (PK) data demonstrated robust...